Somite AI

Somite AI is an artificial intelligence company in Boston, United States, founded in 2024. It has raised $52.3M across 2 rounds, most recently a $47.5M Series A in June 2025.

Cellular Intelligence

Employees
1–10
Founded
2024
Business Model
B2B
Website
somite.ai
Total Funding
$52.3M
Last Round
$47.5M Series AJun 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 6 investors for this company. The full record is or through the API.

About

Somite.ai is pioneering foundation models for human stem cells to drive novel cell therapies at scale. The company takes a full-stack approach — generating differentiation data at approximately 1,000x lower cost than traditional methods using its proprietary capsule technology, training large-scale models with unmatched predictive power, and using these models to discover, refine, and optimize high-impact applications in cell therapy. Its DeltaStem foundation model aims to transform development of therapies for conditions including diabetes, obesity, and muscular dystrophies. The founding team includes repeat AI entrepreneur Dr. Micha Breakstone (Chorus.ai, acquired for $575M), the Head of the Fundamental AI Group at MIT, and three National Academy of Science members. The company launched in January 2024 and has raised approximately $60M including a $47M Series A led by Khosla Ventures.

Summary

It lists 1–10 employees. It has raised $52.3M in total across 2 rounds, most recently a $47.5M Series A round in Jun 2025. Investors include Khosla Ventures, Fusion Fund and TechAviv Founder Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries AJun 2025
$47.5M

Sign up to see all 2 events

Funding: Extension Round through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
OpenAI

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...

San Francisco, United States5001–10000Artificial Intelligence, Generative AI
Corporate RoundTotal funding$179.6BMar 2026
Anthropic

Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...

San Francisco, United States1001–5000Artificial Intelligence, Generative AI
Series G+Total funding$123.7BMay 2026
xAI

xAI builds AI systems, including Grok, with frontier reasoning, voice, and generative media capab...

San Francisco, United States201–500Artificial Intelligence, Generative AI
Series ETotal funding$47.4BJan 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Somite AI on Indexed.vc
<a href="https://indexed.vc/companies/somite-ai"><img src="https://indexed.vc/api/badge/company/somite-ai" alt="Somite AI on Indexed.vc" width="260" height="76" /></a>